BIOMAT Database Logo BIOMAT Database Logo

Synthesis, structure and antibacterial activity of new 2-(1-(2-(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-tetrahydroisoquinoline derivatives. 2009

Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
School of Chemistry and Chemical Engineering, Anhui Key Laboratory of Coal Clean Conversion and Utilization, Anhui University of Technology, Maanshan 243002, PR China. xhliuhx@163.com

A series of new 2-(1-(2-(substituted-phenyl)-5-methyloxazol-4-yl)-3-(2-substitued-phenyl)-4,5-dihydro-1H-pyrazol-5-yl)-7-substitued-1,2,3,4-tetrahydroisoquinoline derivatives were synthesized. The results showed that compounds 9q and 10q can strongly inhibit Staphylococcus aureus DNA gyrase and Bacillus subtilis DNA gyrase (with IC(50s) of 0.125 and 0.25 microg/mL against S. aureus DNA gyrase, 0.25 and 0.125 microg/mL against B. subtilis DNA gyrase). On the basis of the biological results, structure-activity relationships were also discussed.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001412 Bacillus subtilis A species of gram-positive bacteria that is a common soil and water saprophyte. Natto Bacteria,Bacillus subtilis (natto),Bacillus subtilis subsp. natto,Bacillus subtilis var. natto
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D059005 Topoisomerase II Inhibitors Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. DNA Gyrase Inhibitor,DNA Topoisomerase II Inhibitor,Topoisomerase 2 Inhibitors,Topoisomerase II Inhibitor,DNA Gyrase Inhibitors,DNA Topoisomerase II Inhibitors,DNA Type 2 Topoisomerase Inhibitors,Gyrase Inhibitor, DNA,Gyrase Inhibitors, DNA,II Inhibitor, Topoisomerase,Inhibitor, DNA Gyrase,Inhibitor, Topoisomerase II,Inhibitors, DNA Gyrase,Inhibitors, Topoisomerase 2,Inhibitors, Topoisomerase II
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory
D027081 DNA Gyrase A bacterial DNA topoisomerase II that catalyzes ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. Gyrase binds to DNA as a heterotetramer consisting of two A and two B subunits. In the presence of ATP, gyrase is able to convert the relaxed circular DNA duplex into a superhelix. In the absence of ATP, supercoiled DNA is relaxed by DNA gyrase. DNA Gyrase A Subunit,DNA Gyrase B Subunit,DNA-Gyrase,GyrA Protein,GyrB Protein

Related Publications

Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
5-Bromo-2-[5-(4-nitro-phen-yl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]pyrimidine.
November 2009, Acta crystallographica. Section E, Structure reports online,
Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
1-[3-(4-Fluoro-phen-yl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethanone.
September 2012, Acta crystallographica. Section E, Structure reports online,
Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
4-(5-Oxo-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)benzene-sulfonamide.
September 2011, Acta crystallographica. Section E, Structure reports online,
Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
6-Chloro-2-methyl-4-phenyl-3-[1-phenyl-5-(2-thien-yl)-4,5-dihydro-1H-pyrazol-3-yl]quinoline.
October 2009, Acta crystallographica. Section E, Structure reports online,
Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
3-(5-Oxo-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)benzonitrile.
July 2012, Acta crystallographica. Section E, Structure reports online,
Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
6-Chloro-3-[5-(4-fluoro-phen-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-3-yl]-2-methyl-4-phenyl-quinoline.
January 2010, Acta crystallographica. Section E, Structure reports online,
Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
1,5-Dimethyl-4-{[1-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl-idene)eth-yl]amino}-2-phenyl-1H-pyrazol-3(2H)-one.
June 2010, Acta crystallographica. Section E, Structure reports online,
Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
1-{5-[4-(Hex-yloxy)phen-yl]-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl}ethanone.
September 2010, Acta crystallographica. Section E, Structure reports online,
Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
1-[5-(4-Meth-oxy-phen-yl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethanone.
November 2010, Acta crystallographica. Section E, Structure reports online,
Xin-Hua Liu, and Jing Zhu, and An-na Zhou, and Bao-An Song, and Hai-Liang Zhu, and Lin-Shan Bai, and Pinaki S Bhadury, and Chun-Xiu Pan
Synthesis and antibacterial activity of a new series of 3-[3-(substituted phenyl)-1-phenyl-1H-pyrazol-5-yl]-2H-chromen-2-one derivatives.
December 2012, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!